AydF. J.: Prolonged pharmacotherapy and the eye.Int. Drug Therapy Newsletter,1: 9, 1–4, 1966.
2.
CohenLord: Clinical effects of interaction between drugs.Proc. Roy. Soc. Med.,58: 943–993, 1965.
3.
GombosG. M., and YardenP. E.: Ocular and cutaneous side effects after prolonged chlorpromazine treatment.Amer. J. Psychiat.,123: 7, 872–874, 1967.
4.
HoldenJ. M. C., AlvarezU., and ItilT. M.: Changes in laboratory values with butaperazine.Cterr. Ther. Res.,10: 6, 304–312, 1968.
5.
HoldenJ. M. C., and ItilT. M.: The application of automated techniques in assessing psychotropic drug-induced side effects.Amer. J. Psychiat.,125: 4, 562–569, 1968.
6.
HoldenJ. M. C., ItilT. M., KeskinerA., and FinkM.: Thioridazine and chlordiazepoxide, alone and combined, in the treatment of chronic schizophrenia.Comp. Psych.9: 6, 633–643, 1968.
7.
HoldenJ. M. C., ItilT., SimeonJ., and FinkM.: Clinical laboratory test standards in new drug trials.J. Clin. Pharm.,7: 1, 1–8, 1967.
8.
HollisterL. E.: Toxicity of psychotherapeutic drugs.Practitioner,194: 72–84, 1965.
9.
ItilT. M., HoldenJ. M. C., FinkM., ShapiroD., and KeskinerA.: The treatment of chronic psychotic patients with combined medications.Exc. Med., Int. Congr. Series,129: 1016–1020, 1967.
10.
MefferdR. B., LabrosseE. H., GawienowskiA. M., and WilliamsR. J.: Influence of chlorpromazine on certain biochemical variables of chronic male schizophrenics.J. Nerv. and Ment. Dis.,127: 167, 178, 179, 1958.
11.
MeylerL. (Ed.): Side Effects of Drugs.Exc. Med. Found., 5th Ed., 47–76, 1966.
12.
MoserR. H.: Reactions to phenothiazines and related drugs.Clin. Pharm. and Ther.,7: 5, 683–697, 1966.
13.
ReinhardtD. J., TausigT., and ReinaldoA.: Serum cholesterol elevation with tri-fluoperazine (Stelazine) therapy.Delaware Med. J., 318–323, 1962.
14.
RizzoE. M., and RussoS.: Sulle modificazioni ematologiche indotte day largactil.Ross. Stud. Psichiat.,42: 633–640, 1953.
15.
RowntreeD. W., and KayW. W.: Clinical, biochemical and psychological studies in cases of recurrent schizophrenia.J. Ment. Sci.,98: 100–121, 1952.
16.
SimpsonG. M., and CooperT. B.: The effect of three butyrophenones on serum cholesterol levels.Curr. Ther. Res.,8: 5, 249–254, 1966.